IRF4 and myeloid neoplasm: IRF4 exerts oncogenic effects in a lineage- and stage-specific manner: it acts as a tumor suppressor in immature lymphoid and myeloid neoplasms, but is overexpressed by various mature lymphoid neoplasms50.